Trailing-twelve-month (TTM) revenue is $4.12 Billion with a year-over-year growth of +3.71%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,067,376,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $951,199,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-23 |
| Q1 FY2026Period ended 2026-03-31 | $1,012,028,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q2 FY2026Period ended 2026-06-30 | $1,089,796,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $4,120,399,000 |
Current P/S: $10,293,702,826 market capitalization ÷ $4,120,399,000 TTM revenue = 2.50x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.09B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:15:43.924Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Policy Issuance and Renewal Services | N/A | N/A | $2.1B | $2.4B | $2.9B | $3.1B |
| Service Agreement | $28M | $26M |
$4.12B
$4.12 Billion
+3.71%
vs. $3.97B a year ago (TTM)
+9.88%
5 Year compound annual growth rate
1 Year
+3.71%
3 Year
+10.74%
5 Year
+9.88%
10 Year
+30.22%
15 Year
(1.49%)
20 Year
+6.41%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.07B | +$272.14M | +7.17% |
| 2024 | $3.80B | +$526.17M | +16.10% |
| 2023 | $3.27B | +$428.82M | +15.10% |
| 2022 | $2.84B | +$206.15M | +7.83% |
| 2021 | $2.63B | +$97.49M | +3.84% |
| 2020 |
TTM Growth
+3.71%
3-Year CAGR
+10.74%
5-Year CAGR
+9.88%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $26M |
| $26M |
| $25M |
| $2.54B |
| +$59.19M |
| +2.39% |
| 2019 | $2.48B | +$95.09M | +3.99% |
| 2018 | $2.38B | +$690.44M | +40.81% |
| 2017 | $1.69B | +$95.14M | +5.96% |
| 2016 | $1.60B | +$91.12M | +6.05% |
